A recent study conducted at the University of California, San Francisco, suggests that it's possible to predict if women with breast cancer will develop tumors, according to the San Francisco Chronicle
Over an 8-year period researchers looked at 1,162 women who had been diagnosed with Ductal Carcinoma in Situ (DCIS), which is the most common type of noninvasive breast cancer. All of the patients had a lumpectomy procedure performed. Researchers then looked at certain biomarkers in each woman over the 8-year period.
Every year over 60,000 women are diagnosed with DCIS. The study is giving doctors and patients more insight into what may be causing the cancer and what treatments they should undergo.
"Many people are diagnosed with these pre-malignancies and become alarmed. The problem is that only 1 in 10 cases is going to be associated with future invasive cancer," Thea Tlsty, a pathology professor at UCSF and a lead author of the study, to the news source. She feels this research can help patients and doctors make the right decision when it comes to treatment.
Researchers do caution that, though the research is very promising, it may take years before their findings are implemented into how women are diagnosed and treated for the disease.